Wearing-Off Scales in Parkinson's Disease: Critique and Recommendations

被引:89
|
作者
Antonini, Angelo [1 ]
Martinez-Martin, Pablo [2 ,3 ]
Chaudhuri, Ray K. [4 ,5 ]
Merello, Marcelo [6 ]
Hauser, Robert [7 ]
Katzenschlager, Regina [8 ]
Odin, Per [9 ]
Stacy, Mark [10 ]
Stocchi, Fabrizio [11 ]
Poewe, Werner [12 ]
Rascol, Oliver [13 ]
Sampaio, Cristina [14 ]
Schrag, Anette [15 ]
Stebbins, Glenn T. [16 ]
Goetz, Christopher G. [17 ]
机构
[1] IRCCS San Camillo, Dept Parkinsons Dis & Movement Disorders, Venice, Italy
[2] Carlos III Inst Hlth, Area Appl Epidemiol, Natl Ctr Epidemiol, Madrid, Spain
[3] Carlos III Inst Hlth, CIBERNED, Madrid, Spain
[4] Kings Coll London, Natl Parkinson Fdn Ctr Excellence, London, England
[5] Inst Psychiat, London, England
[6] FLENI, Movement Disorders Sect, Buenos Aires, DF, Argentina
[7] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA
[8] Danube Hosp SMZ Ost, Dept Neurol, Vienna, Austria
[9] Cent Hosp, Dept Neurol, Bremerhaven, Germany
[10] Duke Univ, Med Ctr, Durham, NC USA
[11] IRCCS San Raffaele, Inst Neurol, Rome, Italy
[12] Univ Innsbruck Hosp, Dept Neurol, A-6020 Innsbruck, Austria
[13] Lab Pharmacol Med & Clin, Toulouse, France
[14] Lisbon Sch Med, Lab Clin Pharmacol & Therapeut, Lisbon, Portugal
[15] UCL, Dept Clin Neurosci, Inst Neurol, London, England
[16] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA
[17] Rush Univ, Med Ctr, Dept Neurol Serv, Chicago, IL 60612 USA
关键词
Parkinson's disease; wearing-off; clinimetrics; psychometrics; rating scales; validity; reliability; DUODENAL LEVODOPA INFUSION; MOTOR FLUCTUATIONS; DOUBLE-BLIND; PATIENT QUESTIONNAIRE; HOME DIARY; VALIDATION; ISTRADEFYLLINE; PROGRESSION; EFFICACY; TOOL;
D O I
10.1002/mds.23875
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Wearing-off occurs in the majority of patients with Parkinson's disease after a few years of dopaminergic therapy. Because a variety of scales have been used to estimate wearing-off, the Movement Disorder Society commissioned a task force to assess their clinimetric properties. A systematic review was conducted to identify wearing-off scales that have either been validated or used in Parkinson's patients. A scale was designated "Recommended" if it had been used in clinical studies beyond the group that developed it, if it had been specifically used in Parkinson's disease reports, and if clinimetric studies had established that it is valid, reliable, and sensitive. "Suggested" scales met 2 of the above criteria, and those meeting 1 were "Listed." We identified 3 diagnostic and 4 severity rating scales for wearing-off quantification. Two questionnaires met the criteria to be Recommended for diagnostic screening (questionnaires for 19 and 9 items), and 1 was Suggested (questionnaire for 32 items). Only the patient diaries were Recommended to assess wearing-off severity, with the caveat of relatively limited knowledge of validity. Among the other severity assessment tools, the Unified Parkinson Disease Rating Scale version 3 and the version revised from the Movement Disorders Society were classified as Suggested, whereas the Treatment Response Scale was Listed. (C) 2011 Movement Disorder Society
引用
收藏
页码:2169 / 2175
页数:7
相关论文
共 50 条
  • [1] Anxiety Rating Scales in Parkinson's Disease: Critique and Recommendations
    Leentjens, Albert F. G.
    Dujardin, Kathy
    Marsh, Laura
    Martinez-Martin, Pablo
    Richard, Irene H.
    Starkstein, Sergio E.
    Weintraub, Daniel
    Sampaio, Christina
    Poewe, Werner
    Rascol, Oliver
    Stebbins, Glenn T.
    Goetz, Christopher G.
    MOVEMENT DISORDERS, 2008, 23 (14) : 2015 - 2025
  • [2] The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease
    Stacy, Mark
    JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (07) : 837 - 846
  • [3] Apathy and Anhedonia Rating Scales in Parkinson's Disease: Critique and Recommendations
    Leentjens, Albert F. G.
    Dujardin, Kath
    Marsh, Laura
    Martinez-Martin, Pablo
    Richard, Irene H.
    Starkstein, Sergio E.
    Weintraub, Daniel
    Sampaio, Cristina
    Poewe, Werner
    Rascol, Oliver
    Stebbins, Glenn T.
    Goetz, Christopher G.
    MOVEMENT DISORDERS, 2008, 23 (14) : 2004 - 2014
  • [4] Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations
    Evans, Andrew H.
    Okai, David
    Weintraub, Daniel
    Lim, Shen-Yang
    O'Sullivan, Sean S.
    Voon, Valerie
    Krack, Paul
    Sampaio, Cristina
    Post, Bart
    Leentjens, Albert F. G.
    Martinez-Martin, Pablo
    Stebbins, Glenn T.
    Goetz, Christopher G.
    Schrag, Anette
    Bhidayasiri, Roongroj
    Brown, Richard G.
    Marinus, Johan
    Mestre, Tiago A.
    Violante, Mayela Rodriguez
    Skorvanek, Matej
    MOVEMENT DISORDERS, 2019, 34 (06) : 791 - 798
  • [5] Wearing-off in Parkinson's disease: neuropsychological differences between on and off periods
    Caillava-Santos, Fabiane
    Margis, Regina
    de Mello Rieder, Carlos Roberto
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1175 - 1180
  • [6] Rotigotine for anxiety during wearing-off in Parkinson's disease with dementia
    Fanciulli, Alessandra
    Assogna, Francesca
    Caltagirone, Carlo
    Spalletta, Gianfranco
    Pontieri, Francesco E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 25 (05) : 601 - 603
  • [7] The Risk Factors for the Wearing-Off Phenomenon in Parkinson's Disease
    Raja, Kunal
    Ramrakhia, Sonam
    Dev, Kapeel
    Shahid, Wajeeha
    Sohail, Hamza
    Memon, Muhammad Khizar
    Memon, Sidra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [8] Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease
    Abbruzzese, Giovanni
    Antonini, Angelo
    Barone, Paolo
    Stocchi, Fabrizio
    Tamburini, Tiziano
    Bernardi, Laura
    Amboni, Marianna
    Vacca, Laura
    Posocco, Valeria
    Colombo, Delia
    NEUROLOGICAL SCIENCES, 2012, 33 (06) : 1319 - 1327
  • [9] Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone
    Reichmann, Heinz
    Emre, Murat
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (02) : 119 - 131
  • [10] Levodopa-related wearing-off in Parkinson's disease: identification and management
    Pahwa, Rajesh
    Lyons, Kelly E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 841 - 849